TEM-187, a new extended-spectrum β-lactamase with weak activity in a Proteus mirabilis clinical strain. [electronic resource]
- Antimicrobial agents and chemotherapy May 2013
- 2410-2 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
1098-6596
10.1128/AAC.01761-12 doi
Amino Acid Substitution Anti-Bacterial Agents--pharmacology Base Sequence Drug Resistance, Multiple, Bacterial--genetics Humans Microbial Sensitivity Tests Molecular Sequence Data Proteus Infections--drug therapy Proteus mirabilis--drug effects beta-Lactamases--genetics